U.S. breathalyzer maker's Q2 revenue rose 10% yr/yr
Q2 net loss narrowed from prior year as gross margin improved to 45%
Company secured $500,000 loan from Chairman and CFO during the quarter
Drivers of the quarter
Price increases and product mix - The company said higher gross margin was driven by price increases and a favorable product mix.
R&D spending - The company said continued high research and development investment, mainly for SpinDetect analyzer development, contributed to the net loss.
Product line strength - The company said its core alcohol detection products and new L-series devices supported market penetration and incremental sales.
Outlook for SpinDetect
Company targets limited commercial launch of SpinDetect analyzer in Q1 2027
LCTC•
